Onset/offset characteristics and intubating conditions of rapacuronium: a comparison with rocuronium

Area of Science:

• Anesthesiology
• Pharmacology
• Critical Care Medicine

Background:

• Neuromuscular blocking agents are crucial for facilitating endotracheal intubation.
• Rocuronium is a commonly used non-depolarizing neuromuscular blocker.
• Rapacuronium is a newer agent with potential advantages in onset and offset of action.

Purpose of the Study:

• To compare the onset and offset of neuromuscular block and tracheal intubating conditions between rapacuronium and rocuronium.
• To evaluate the impact of maintenance anesthesia (propofol or sevoflurane) on the efficacy of these agents.

Main Methods:

• A randomized, assessor-blinded study involving 60 patients undergoing anesthesia.
• Patients received either rapacuronium (1.5 mg kg-1) or rocuronium (0.6 mg kg-1) after propofol induction.
• Neuromuscular monitoring was performed using an electromyographic (EMG) device (Datex Relaxograph).

Main Results:

• Rapacuronium demonstrated a significantly shorter onset time (87 s vs 141 s) and a greater degree of block at 60 seconds (69% vs 50%) compared to rocuronium.
• Both agents provided similar lag times, maximum block, and excellent intubating conditions at 60 seconds (86% vs 84%).
• Recovery (25% return of muscle function) was significantly shorter with rapacuronium (approx. 15 min) than rocuronium (approx. 39-48 min) regardless of maintenance anesthesia.

Conclusions:

• Rapacuronium 1.5 mg kg-1 provides a more rapid onset of neuromuscular block and faster recovery compared to rocuronium 0.6 mg kg-1.
• Intubating conditions and maximum neuromuscular block were comparable between the two agents.
• Rapacuronium may offer clinical advantages due to its faster onset and offset characteristics.